Annual Scientific Meeting

PRESENTED BY:  Henry Ford Health System

OBJECTIVES: 

1. List terminology and definitions of fetal growth restriction.
2. Describe the different etiologies and risk factors for fetal growth restriction.
3. Explain current preventive measures.
4. Describe current tools for the diagnosis of fetal growth restriction.
5. Discuss current recommendations for treatment, monitoring, and timing of delivery.
6. Identify and assess risk factors in patients with chronic pelvic pain for persistent pain after surgery.
7. Report those clinical factors predictive of positive response to surgery in chronic pelvic pain.
8. Integrate treatment and referral plans in their practice to defer surgery in favor of conservative management.
9. Discuss new hormonal therapies. 
10. Identify what is new in non-hormonal therapy.  
11. Discuss risks/benefits of hormonal replacement therapy.
12. Discuss hormonal replacement therapy in special populations - women with history of breast or endometrial cancer.
13. Identify key ways providers can address sexual concerns in the clinical setting. 
14. Discuss important aspects of sexual history taking and physical exam as they relate to low desire. 
15. Name the categories of desire and discuss the dual control model as it relates to sexual desire. 
16. Name common treatment strategies for low desire and desire discrepancy.
17. Discuss the multidisciplinary approach to addressing sexual concerns and the role of collaboration and referrals.

COURSE DIRECTOR:  Roopina Sangha, MD, MPH, CPE, FACOG, Program Director, OBGYN Residency Program, Henry Ford Hospital, Detroit

SPEAKERS: 

Majid Shaman, MD, Maternal and Fetal Medicine, Obstetrics and Gynecology, Henry Ford Health System, Detroit
Management of Fetal Growth Restriction

David Eisenstein, MD, Obstetrics and Gynecology, Henry Ford Health System, Detroit

Laparoscopy for Pelvic Pain

Nicole Budrys, MD, Obstetrics and Gynecology, Henry Ford Health System, Detroit
What's New in Menopausal Medicine?

Philis Mims-Gillum, MD, Obstetrics and Gynecology, Henry Ford Health System, Detroit
The Pleasure Principle:  Addressing Female Sexuality, Desire, and Desire Discrepancy in Clinical Practice

PRESENTED BY: Michigan Dermatological Society (MDS)

OBJECTIVES:

1.    Discuss the latest updates in contact dermatitis.
2.    Describe clinical development in chronic wound care and hyperbaric oxygen.
3.    Explain the dermatological manifestations of rheumatologic disease.

COURSE CO-DIRECTORS: Alice Watson, MD, Chair, MDS CME Committee, Ann Arbor; Steve Daveluy, MD, MDS CME Committee, Detroit; and Kelly Harms, MD, MDS CME Committee, Ann Arbor

SPEAKERS:

Holly Kerr, MD, Dermatology Residency Program Director, Henry Ford Health System

Updates in Contact Dermatitis

Steven Haase, MD, Associate Professor, Section of Plastic Surgery, University of Michigan Health System, Ann Arbor

Chronic Wound Care and Hyperbaric Oxygen

Kathleen Maksimowicz-McKinnon, DO, Rheumatologist, Henry Ford Health System, Detroit

Dermatological Manifestations of Rheumatologic Disease

PRESENTED BY: Practice Transformation Institute

OBJECTIVES:

1. Identify how social determinants of health can impact the patient’s treatment and outcomes.
2. Describe tools and processes that can be used to systematically capture and address SDOH needs of patients.
3. Discuss strategies that can improve effectiveness of history taking.

COURSE DIRECTOR: Ewa Matuszewski, Principal, Practice Transformation Institute, Troy

SPEAKERS:  
Al Juocys, DO, Chief Medical Officer, Medical Network One, Rochester
Using Team Care to Address Social Determinants of Health

 

Neeli Thati, MD, Associate Program Director Internal Medicine and Assistant Professor, Department of Internal Medicine, Wayne State University School of Medicine, Detroit
Capturing and Weaving SDOH Into My Practice’s Workflow

Teresa Choate, MS, Director, Special Projects, Medical Network One, Rochester
Reducing the Health Care Only Approach: Tips and Tools

 

Mary Beth Bolton, MD, Medical Director, Customer Reporting and Analytics and Medical Director; Blue Cross Blue Shield of Michigan, Livonia
Shifting Long-term Services and Supports in the Home and Community
Rather than in Institutions

PRESENTED BY:  University of Michigan Health System

OBJECTIVES: 

1. Describe populations best treated with aspirin for heart disease.
2. Explain target blood pressure goals.
3. Identify populations which cardiac conditions should be referred to specialists with an interest in genetic associations of heart disease.
4. State what level of PVC’s burden should be referred to cardiovascular specialist.

COURSE DIRECTOR:  Peter Farrehi, MD, Assistant Professor of Internal Medicine, University of Michigan Medical School, Ann Arbor

SPEAKERS:

Doctor Farrehi
What is the Right Dose of Aspirin for Secondary Prevention?

 Sara Saberi, MD, Assistant Professor of Internal Medicine, University of Michigan Medical School, Ann Arbor
Genetic Testing in CV Disease

Kenneth Jamerson, MD, Frederick G. L. Huetwell, MD, Collegiate Professor of Cardiovascular Medicine and Professor of Internal Medicine, University of Michigan Medical School, Ann Arbor
Hypertension Guidelines: What You Need to Know

Mohammed Saeed, MD, Clinical Lecturer in Internal Medicine, University of Michigan Medical School, Ann Arbor
Premature Contractions: What a Primary Doctor Needs to Know

PRESENTED BY:  Michigan State University College of Human Medicine

OBJECTIVES: 

1. Describe the initiation and intensification of insulins in the treatment of diabetesm ellitus type 2 and newer basal insulins available.
2. Develop a comprehensive assessment of osteoporosis.
3. Explain the current and newer treatment options and be aware of potential complications of treatment.
4. Discuss thyroid hormone physiology and be aware of potential interferences to laboratory testing of thyroid function testing.
5. List connections of pituitary to thyroid, adrenal, and gonads.
6. Discuss case examples of hypopituitarism and hyperpituitarism.
7. Review diagnosis and treatment of male hypogonadism by case example.
8. Recognize the definition of resistant hypertension. Review important endocrine contributions and treatment.

COURSE DIRECTOR:  Naveen Kakumanu, MD, Assistant Professor of Medicine, Michigan State University College of Human Medicine, East Lansing

SPEAKERS:

Ved Gossain, MD, FRCP (c), MACP, FACE, Swartz Professor of Medicine and Chief, Division of Endocrinology (Emeritus-Active), Michigan State University College of Human Medicine, East Lansing
Insulin Initiation and Intensification – Taking Out the Confusion!

Saleh Aldasouqi, MD, FACE, ECNU, Associate Professor of Medicine, Michigan State University College of Human Medicine, East Lansing
Caution!! Beware of Interferences and Supplements with Thyroid Function
Testing

Doctor Kakumanu
Bad to the Bone – Assessment and Treatment of Osteoporosis

J. David Faichney, MD, FACP, Clinical Associate Professor, Michigan State University College of Human Medicine; and Staff Physician, Munson Health Care, Traverse City
Pituitary Disease 101 for the Primary Care Physician

G. Matthew Hebdon, MD, PhD, Assistant Professor of Medicine, Michigan State University College of Human Medicine, East Lansing
Too High! – The Endocrine Evaluation of Resistant Hypertension

PRESENTED BY:  Michigan Otolaryngologic Society

OBJECTIVES: 

1. Describe any updates of diagnosis and treatment of HPV and Oropharyngeal cancer.
2. Discuss what the primary care physician needs to know about hoarseness guidelines. 
3. The latest clinical findings on pediatric head and neck masses and when the PCP should refer to a specialist.

COURSE CO-DIRECTORS:  Michael Haupert, DO, and Ross Mayerhoff, MD, Henry Ford Health System

SPEAKERS:

Vivian Wu, MD, Otolaryngologist, Henry Ford Health System, Detroit
HPV and Oropharyngeal Cancer

Robert Stachler, MD, Otolaryngologist, Beaumont Hospital, Royal Oak
Hoarseness Guidelines

John Bangiyev, DO, Otolaryngologist, Beaumont Hospital, Royal Oak
Pediatric Head and Neck Masses

PRESENTED BY: Michigan Medicine, Department of Otolaryngology, Head and Neck Medicine

OBJECTIVES:

1. Discuss the impact that hearing loss has both adults and children.
2. Identify strategies to discuss hearing loss with patients to identify those in need of a referral for hearing testing.
3. Explain current technologies that can be used to foster improved hearing for patients with hearing loss.
4. Discuss how to increase the awareness of hearing loss intervention on and implement strategies for improved outcomes for patients with hearing loss.

COURSE DIRECTOR: Teresa Zwolan, PhD, Professor, Department of Otolaryngology; and Director, Cochlear Implant Program, Michigan Medicine, Ann Arbor   

SPEAKER:

Doctor Zwolan
Recent Updates in Hearing Loss Diagnosis and Treatment:  Professional and Parental Perspectives

Andrew Shuman, MD, Assistant Professor, Otolaryngology, Michigan Medicine, Ann Arbor
Recent Updates in Hearing Loss Diagnosis and Treatment:  Professional and Parental Perspectives

OBJECTIVES:

1. Apply the CDC Guidelines for opioid use to their practice. 
2. When utilizing the CDC Guidelines and the new Michigan Opioid Laws, recognize the lack of high quality evidence regarding the claimed lack of benefits of opioids, and be willing to utilize this caveat in treating individual patients.
3. List the controversies in the current CDC reports of opioid overdose deaths, including involvement of other drugs and the over-representation of Fentanyl in opioid overdose deaths.

COURSE DIRECTOR:  Carl Christensen MD, D-FASAM, Clinical Associate Professor, Department Psychiatry, Wayne State University School of Medicine, Tolan Research Clinic; Medical Director, Michigan Health Professional Recovery Program; Medical Director, Dawn Farm; and Christensen Recovery Services, Ann Arbor

SPEAKERS:

Doctor Christensen
The CDC Guidelines for Opioid Prescribing and the New Michigan
Opioid Laws

William Morrone, DO, D-ABAM, ASAM, Medical Director, 35th District Shiawassee County Treatment Court; Deputy Chief Medical Examiner, Bay County; and Medical Director, Recovery Pathways
The CDC Guidelines for Opioid Prescribing and the New Michigan
Opioid Laws

PRESENTED BY: Henry Ford Health System

OBJECTIVES:

1. Describe recent updates in epidemiology, diagnostic testing, and management of emerging issues in infectious diseases, including HIV, prosthetic joint infection, skin, and soft tissue infections.
2. Discuss the work up and management of disease process that mimic infection.
3. Discuss and apply to patient care the updated immunization schedule for adults.

COURSE DIRECTOR: Indira Brar, MD, Senior Staff, Infectious Diseases, Henry Ford Health System, Detroit

SPEAKERS:

George Alangaden, MD, Senior Staff, Infectious Diseases, Henry Ford Hospital; and Professor of Medicine, Wayne State School of Medicine, Detroit
The Vaccines You’ve Been Missing: An Update on Adult Immunization

Anne Chen, MD, Program Director, Infectious Diseases Fellowship, Henry Ford Health System, Detroit
Skin and Soft Tissue Infection: Not Always That Simple

Odaliz Abreu Lanfranco, MD, Program Director, Internal Medicine, Henry Ford Health System, Detroit
Imitators of Infection

Mayur Ramesh, MD, Senior Staff, Infectious Diseases, Henry Ford Health System, Detroit
How and When to Use Stool for the Management of Clostridium Difficile Infection: The Updated IDSA Guidelines

Erica Herc, MD, Senior Staff, Infectious Diseases, Henry Ford Hospital, Detroit
Handy Tips from an Infectious Diseases Doctor for the Management of Prosthetic Joint Infection

 John McKinnon, MD, Senior Staff, Infectious Diseases, Henry Ford Hospital, Detroit

HIV Update

PRESENTED BY: Physicians for the Prevention of Gun Violence (PPGV)

OBJECTIVES:

1. Describe comparative international prevalence data on firearm safety and violence.
2. Explain the personal and financial costs of gun violence.
3. Identify at-risk patients and families during regular office appointments and at the time of Emergency Department visits. 
4. Explain to patients and families the seriousness of their risks and how to mitigate them. 

PRESENTED BY: Children’s Hospital of Michigan, Division of Emergency Medicine

OBJECTIVES:

1. Identify and manage infants and children who present to the Emergency Department (ED) or urgent care setting with presentations concerning for abuse with special emphasis on unusual or occult presentations. 

2. Recognize and manage infants and children who present to the ED or urgent care setting with skin manifestations of abuse.

3. Describe and manage infants and children who present to the ED or urgent care setting with orthopedic manifestations of abuse.

4. Discuss and manage infants and children who present to the ED or urgent care setting with presentations that are concerning for abuse but are subsequently found to represent other medical conditions.

COURSE DIRECTOR: 

Earl R. Hartwig, MD, Education Director, Clinical Associate Professor of Pediatrics and Emergency Medicine, Division of Pediatric Emergency Medicine, Children's Hospital of Michigan, Wayne State University School of Medicine, Detroit

SPEAKERS:

Amy Cortis, MD, Director of Emergency Medicine, Children's Hospital Troy, Clinical Assistant Professor of Pediatrics and Emergency Medicine, Children's Hospital of Michigan, Wayne State University School of Medicine, Detroit
If You Don't Look... Skin Manifestations of Abuse

 Rajan Arora, MD, FAAP, Associate Director, Quality Improvement, Assistant Professor of Pediatrics and Emergency Medicine, Children's Hospital of Michigan, Wayne State University School of Medicine, Detroit
Is It Real or Not? - Mimics of Abuse

Stephanie Do, DO, Co-Director Pediatric Emergency Education, Clinical Assistant Professor of Pediatrics and Emergency Medicine, Children's Hospital of Michigan, Wayne State University School of Medicine, Detroit
Unexpected Presentations of Abuse

Katherine Hebert, MD, Fellowship Director Pediatric Emergency Medicine, Clinical Assistant Professor of Pediatrics and Emergency Medicine, Children's Hospital of Michigan, Wayne State University School of Medicine, Detroit
Orthopedic Aspects of Abuse

PRESENTED BY: Karmanos Cancer Institute and Wayne State University School of Medicine
OBJECTIVES:

1. Discuss how immunotherapy works and it’s use in cancer treatment.
2. Explain the toxicity of cancer immunotherapy and its management.
3. List biologic and targeted treatments available in cancer treatment.
4. Report general toxicities of biologic and targeted cancer treatments and their management.
5. Describe new developments in lung cancer treatment.

COURSE DIRECTOR: Anteneh Tesfaye, MD, Assistant Professor of Medicine and Oncology, Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit

SPEAKERS:
Doctor Tesfaye
Immunotherapy in Cancer: A Rapidly Expanding Treatment

Misako Nagasaka, MD, Assistant Professor of Medicine and Oncology, Thoracic and Head and Neck Oncology, Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit
Lung Cancer: Early Detection, Molecular Profiling, and Emerging Therapies

Ulka Vaishampayan, MD, Professor of Medicine and Oncology, Genitourinary Oncology, Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit
Managing the Complications of Biological and Targeted Cancer Therapies

PRESENTED BY:  Michigan Urological Society

OBJECTIVES:

1. Discuss the current guidelines for the evaluation and treatment of male infertility.

2. List the latest clinical developments in the evaluation and treatment of female urinary incontinence.

3. Explain Microhematuria initial work-up and follow-up recommendations from the American Urological Association (AUA).

4. Discuss increased awareness of active surveillance and focal treatment for prostate cancer focal treatment.

5. List the PSA screening guidelines from the AUA.

6. Describe Benign Prostate Hyperplasia evaluation and treatment.

COURSE DIRECTOR: Ali A. Dabaja, MD, Director, Male Reproductive Medicine and Sexual Medicine, Henry Ford Hospital Health System, Detroit

SPEAKERS: 
Doctor Dabaja
Evaluation and Treatment of Male Infertility
Humphrey O. Atiemo, MD, Director, Female Pelvic Medicine and Reconstructive Surgery, Henry Ford Health System, Detroit
Evaluation and Treatment of Female Urinary Incontinence
Shaheen Alanee, MD, Staff Urologist, Henry Ford Health System, Detroit
Microhematuria
Mani Menon, MD, Chair, Department of Urology, Henry Ford Health System, Detroit
Prostate Cancer Focal Treatment
James O. Peabody, MD, Chief of Urology, Henry Ford Health System, Detroit
PSA screening and Prostate Cancer Active Surveillance
Joseph Haddad, MD, Staff Urologist, Henry Ford Health System, Detroit
Benign Prostate Hyperplasia

 

PRESENTED BY: Michigan Society of Colon and Rectal Surgeons

OBJECTIVES:

1. Explain screening for hereditary colon cancer.
2. Discuss a watch and wait approach for rectal cancer patients.
3. Describe an enhanced recovery program for postoperative colorectal surgery patients.
4. Discuss appropriate utilization of pelvic exenterations for pelvic malignancies.

COURSE DIRECTOR: Nadav Dujovny, MD, Colon and Rectal Surgeon, Spectrum Health Medical Group/Ferguson Clinic, Grand Rapids

SPEAKERS: 

Arida Siripong, MD, Colon and Rectal Surgeon, Spectrum Health Medical Group, Grand Rapids

Watch and Wait Approach for Rectal Cancer

Amanda McClure, MD, Colon and Rectal Surgeon, St. Joseph Mercy Hospital, Ann Arbor
Enhanced Recovery Program for Colorectal Surgery

Doctor Dujovny
Hereditary Colorectal Cancer

Karin Hardiman, MD, PhD, Assistant Professor of Surgery, University of Michigan, Ann Arbor
Utilization and Outcomes of Pelvic Exenteration

Ernesto Drelichman, MD, Colon and Rectal Surgeon, St. John/Providence Health System, Southfield
Colon Cancer Screening in the Age of Fecal DNA and Blood Tests

PRESENTED BY:  Henry Ford Health System

OBJECTIVES:

1. Identify medication induced movement disorders.
2. Discuss signs for serotonin syndrome.
3. Explain of high risk drug-drug interactions.
4. List common neurologic issues in pregnancy.  
5. Discuss treatment of epilepsy in pregnancy.
6. Describe evaluation and treatment of headaches in pregnancy.
7. Explain how to differentiate between primary and secondary headaches.
8. Report the most common primary headaches - migraines, tension, cluster, and hemicranias.
9. Discuss common secondary headaches: medication overuse, posttraumatic, cervicogenic, thunderclap, intracranial hypertension and hypotension.
10. Discuss indications for ordering additional tests, neuroimaging.
11. Recognize the risk factors for delirium and cognitive decline in hospitalized patients. 
12. Explain the pathophysiology behind these changes.
13. Identify strategies to mitigate or eliminate these changes. 
14. List what aspects of the history are most useful in determining the etiology of spells.
15. Recognize the common features in history or on exam which help determine the etiology of spells, and how to reduce the risks associated with them. 
16. Identify uncommon etiologies of spells. 

 

PRESENTED BY: Michigan State University College of Human Medicine

OBJECTIVES:

1. Identify and evaluate early environmental and lifestyle risk factors relevant to breast cancer.

2. Apply the ‘precautionary principle” in interactions with patients and providers as a strategy for taking action to reduce adolescents’ environmental exposures.

3. Evaluate the role of BPA, PFOA, PBDE, and Phthalates as environmental risk factors on the development of breast cancer later in life.

4. Discuss the relationship between environmental and lifestyle risk factors, the pubertal window of susceptibility, and risk breast cancer later in life.

5. Recognize the concept of “window of susceptibility” as a period where females are more vulnerable to environmental exposures and can define and distinguish between different windows. 

COURSE DIRECTOR:  Sandi W. Smith, PhD, Distinguished Professor, Communication, Michigan State University, East Lansing

PRESENTED BY: Oakland County Medical Society

OBJECTIVES: 

1. To facilitate the new Michigan 2014 PA 341 & 343 Law that mandates Human Trafficking training for medical and dental professionals and the provision of Medical Assistance of human trafficking victims.
2. Describe the types and venues of human trafficking in the United States.
3. Identifying victims of human trafficking in health care settings.
4. Explain the warning signs of human trafficking in health care settings for adults and minors.

COURSE DIRECTOR: Cindy Dady, Executive Director, Oakland County Medical Society, Bloomfield Hills

SPEAKER:  Stephanie Krieger, Analyst/Engagement Specialist, s7 Consulting, LLC.

PRESENTED BY:  The Doctors Company

OBJECTIVES: 

1. Recognize contributing factors that lead to patient dissatisfaction and possible litigation.
2. Describe strategies to enhance defensibility of care and treatment.
3. Identify resources available through your Medical Professional Liability Insurance Carrier to assist with risk management and patient safety.

COURSE DIRECTOR:  Debra Davidson, MJ, ARM, CPHRM, CPPS, Patient Safety/Risk Manager, The Doctors Company, Northeast Region, East Lansing

SPEAKERS: 

Ms. Davidson

Jennifer Andreou, Partner, Plunkett Cooney

Leslie Rojas, Associate, Plunket Cooney

 

PRESENTED BY:  University of Michigan Medical School

OBJECTIVES: 

1. Discuss the role of thrombectomy in management of ischemic stroke patients.
2. Recognize wake-up and strokes beyond six hours of symptoms.
3. Report on diagnosis and medical management of ischemic stroke.
4. Identify management of hemorrhagic stroke.
5. Describe the endovascular management of hemorrhagic stroke.

COURSE DIRECTOR: Aditya S. Pandey, MD, Surgical Director, Comprehensive Stroke Center; and Associate Professor, Neurosurgery, University of Michigan Medical School, Ann Arbor

SPEAKERS:  

Joseph Gemmete, MD, Professor of Radiology, Michigan Medicine, Ann Arbor
Role of Thrombectomy in Management of Ischemic Stroke Patients

Neeraj Chaudhary, MD, Assistant Professor of Radiology, Michigan Medicine, Ann Arbor
Wake-Up and Strokes Beyond Six Hours of Symptoms

Mollie Mcdermott, MD, Assistant Professor of Neurology, Michigan Medicine, Ann Arbor 
Diagnosis and Medical Management of Ischemic Stroke

B. Gregory Thompson, MD, Professor of Neurosurgery, Michigan Medicine, Ann Arbor
Management of Hemorrhagic Stroke

Augusto Elias, MD, Surgical Director, Neuro-interventional Surgery, Metro Health, Grand Rapids
Endovascular Management of Hemorrhagic Stroke

PRESENTED BY: University of Michigan Health System, CS Mott Children’s Hospital

OBJECTIVES:

1. List the revised guidelines for pediatric hypertension from the AAP.
2. Describe pediatric elevated blood pressures and hypertension in the general care office.
3. Practice the initial evaluation of hypertension.
4. Discuss the revised clinical criteria for diagnosis of urinary tract infection in pediatrics.
5. Describe the diagnosing, treating, and evaluating urinary tract infections in pediatrics.
6. Report on the significant of microscopic hematuria and proteinuria detected on urine dipstick.
7. Explain the initial evaluation of unexpected urinalysis findings in the general care office.

COURSE DIRECTOR:  Rebecca Lombel, MD, Assistant Clinical Professor, Pediatric Nephrology, University of Michigan Health System, C.S. Mott Children’s Hospital, Ann Arbor

SPEAKERS: 

David Selewski, MD, Assistant Professor, Pediatric Nephrology, University of Michigan Health System, Ann Arbor
Suspected UTI in the Office

Jennifer Lai Yee, MD, Fellow, Pediatric Nephrology, University of Michigan Health System, Ann Arbor
Elevated Blood Pressure in the Office

Doctor Lombel
Dipstick Urinalysis in the Office

PRESENTED BY: Ferris State University College of Pharmacy

OBJECTIVES:

1. Discuss outpatient antibiotic prescribing patterns.
2. Explain how to objectively measure antibiotic prescribing patterns. 
3. Discuss how to implement outpatient antimicrobial stewardship initiatives.  

COURSE DIRECTOR:  Michael E. Klepser, PharmD, FCCP, FIDP, Professor, Ferris State University College of Pharmacy, Kalamazoo

SPEAKERS: 

Glenn V. Dregansky, DO, FAAFP, Assistant Professor, Department of Family and Community Medicine; and Program Director, Family Medicine Residency Western Michigan University Homer Stryker, MD School of Medicine, Kalamazoo
Antibiotic Use in the United States Tracking Antibiotic Use in the Outpatient Clinic: Lecture, Workshop, and Cases Incorporating Antimicrobial Stewardship into Practice: Practice Vignettes

Doctor Klepser

Erik Winterholler, MS3, Western Michigan University Homer Stryker, MD School of Medicine, Kalamazoo
Tracking Antibiotic Use in the Outpatient Clinic: Lecture, Workshop, and Cases

Bryant Hammershaimb, MS3, Western Michigan University Homer Stryker, MD School of Medicine, Kalamazoo
Tracking Antibiotic Use in the Outpatient Clinic: Lecture, Workshop, Cases

Joshua Fainsod, MD, Resident, Western Michigan University Homer Stryker, MD School of Medicine, Kalamazoo
Incorporating Antimicrobial Stewardship into Practice: Practice Vignettes

PRESENTED BY:  Wayne County Medical Society of Southeast Michigan

Carl Christensen MD, D-FASAM, Clinical Associate Professor, Department Psychiatry, Wayne State University School of Medicine, Tolan Research Clinic; Medical Director, Michigan Health Professional Recovery Program; Medical Director, Dawn Farm; and Christensen Recovery Services, Ann Arbor

 

PRESENTED BY: Michigan Society of Allergy and Immunology

OBJECTIVES: 

1. Discuss appropriate screening for angioderma.
   Explain angioderma symptoms, diagnosis, and treatment options.
2. Describe symptoms of mast cell activation syndrome.
3. Identify updated treatment guidelines.
4. Discuss screening for eosinophilic lung disease.
5. List the updated treatment guidelines.

COURSE DIRECTOR:  Martin Dubravec, MD, Allergy & Asthma Specialists of Cadillac

SPEAKERS:

Alan P. Baptist, MD, MPH, Assistant Professor, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor
Angioderma

Lawrence B. Afrin, MD, Armonk Integrative Medicine, Armonk, NY
Mast Cell Activation Syndrome 101

Daniel R. Ouellette, MD, Associate Professor of Medicine, Wayne State University School of Medicine, Detroit

Eosinophilic Lung Disease

PRESENTED BY: University of Michigan Medical School

OBJECTIVES: 

1. Discuss common peripheral nerve entrapment syndromes and common and newer interventions available.
2. Explain presentation of common sports neurologic injuries and their management.
3. List the new recommendations for stroke interventions.
4. Describe the new ways that technology is used in the treatment of neurological disorders.
5. Report on the current treatment options available for patients with malignancies of the central nervous system.

COURSE DIRECTOR:  Emily Levin, MD, Clinical Assistant Professor, University of Michigan Medical Center, Ann Arbor 

SPEAKERS: 

Mark Oppenlander, MD, Assistant Professor, Neurosurgery, University of Michigan Medical School, Ann Arbor
Neurosurgical Care of the Athlete with Spine Injury

Aditya Pandey, MD, Associate Professor, Neurosurgery, University of Michigan Medical School, Ann Arbor
Cerebrovascular Update: Stroke is a Treatable Disease

Daniel Orringer, MD, Associate Professor, Neurosurgery, University of Michigan Medical School, Ann Arbor
New Horizons in the Treatment of Brain Tumors

Nick Szerlip, MD, Associate Professor, Neurosurgery, University of Michigan Medical School, Ann Arbor
Management of Tumors of the Spine

Ann Little, MD, Associate Professor, Neurosurgery, University of Michigan Medical School, Ann Arbor
Updates in Surgical Treatment of Peripheral Nerve Pain Entrapment Syndromes

Doctor Levin
Updates in Functional Neurosurgery                                   

PRESENTED BY: Chapman Law Group

LEARNER OBJECTIVES:

1. Prevent risk and spotting diversion in initial patient documentation.
   PDMP usage and pitfalls.
2. The necessary elements of a controlled substance agreement to mitigate civil and criminal liability.
3. Create and effective treatment plan and patient investment in understanding need for a controlled substance agreement and monitoring.
4. Strategies for monitoring compliance with your CSA.
5. The use of ancillary employees in compliance monitoring.
6. Detecting diversion patients while maintaining compassionate care.
7. Effective use of urine drug screens, how to treat inconsistent results.
8. Strategies to avoid patient abandonment and negative outcomes due to the discontinuation of treatment.

COURSE DIRECTOR:  Ronald W. Chapman II, JD, Chapman Law Group, Troy

SPEAKERS: 

Jodi Switalski, JD, The Stutman-Switalski Group, LLC. 
Controlled Substance Agreement (CSA) and Patient Abandonment

Mr. Chapman
Updates on DEA’s Efforts to Detect and Prevent Drug Diversion

Course Director: Daniel Alford, MD, MPH, FACP, DFASAM

The ASAM Treatment of Opioid Use Disorder Course covers the highest quality, evidence- based practices for treating patients with opioid use disorder. This course covers all medications and treatments for opioid use disorder, and provides the required education needed to obtain the waiver to prescribe buprenorphine. This is an 8-hour blended course combining 4 hours of online learning followed by 4 hours of live learning.

• The ASAM Treatment of Opioid Use Disorder Course is designed for:
  Physicians, nurse practitioners, physician assistants, and health care team members working with patients with opioid use disorder.
• Physicians, nurse practitioners, and physician assistants who wish to obtain a waiver to prescribe buprenorphine in office-based treatment of opioid use disorders.

Our case-based learning format will show you how to apply this new knowledge. You will learn how to:

• Have specific knowledge to offer treatments for patients with opioid use disorder.
• Identify and assess patients who are appropriate for treatment with medications.
• Discuss the psychiatric and medical co-morbidities associated with opioid addiction.
• Apply for a waiver to prescribe buprenorphine to patients with opioid use disorders.

ACCME ACCREDITATION STATEMENT: The American Society of Addiction Medicine (ASAM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to sponsor continuing medical education for physicians.

AMA CREDIT DESIGNATION STATEMENT: The American Society of Addiction Medicine designates this enduring material for a maximum of 4 AMA PRA Category 1 Credits™. Physicians should claim credit commensurate with the extent of their participation in the activity.

The American Society of Addiction Medicine designates this live activity for a maximum of 4 AMA PRA Category 1 Credits™. Physicians should claim credit commensurate with the extent of their participation in the activity.

The combined online enduring material and live activity will provide the required 8 hours needed to obtain the waiver to prescribe buprenorphine in office-base treatment of opioid use disorders.

 

Member Status	Cost
MSMS Members	$135 per course
MSMS Members with "Retired Status"	$105 per course
YPS Members	$105 per course
Non-Members	$185 per course
Residents	FREE
Medical Students	FREE

Statement of Accreditation:

The Michigan State Medical Society (MSMS) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA Credit Designation Statement:

The MSMS designates this live activity for a maximum of 25.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

MOC Statement:

Successful completion of this CME activity which includes participation in the evaluation component, enables the participant to earn up to 25.5 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participation completion information to ACCME for the purpose of granting ABIM MOC credit.

ACCME Accreditation Statement:

The American Society of Addiction Medicine (ASAM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA Credit Designation Statement:

ASAM designates this enduring material for a maximum of 4 AMA PRA Category 1 Credits™. Physicians should claim credit commensurate with the extent of their participation in the activity.

ASAM designates this live activity for a maximum of 4 AMA PRA Category 1 Credits™. Physicians should claim credit commensurate with the extent of their participation in the activity.

The combined online enduring material and live activity will provide the required 8 hours needed to obtain the waiver to prescribe buprenorphine in office-base treatment of opioid use disorders.

Centrally located to everything Metro-Detroit, the Sheraton Detroit-Novi Hotel recently went through a multi-million dollar renovation. The MSMS Foundation king/double room rate is $149.00 (plus applicable taxes) per room per night. To receive the special rate, reservation requests must be made by October 1, 2018. When you make your reservations please tell the hotel staff you are with the Michigan State Medical Society; or, you may book online by visiting: https://www.starwoodmeeting.com/Book/MichiganStateMedicalsociety2018.

 
Sheraton Detroit-Novi Hotel
21111 Haggerty Road
Novi, MI 48375
Phone: 866-716-8134 or 248-349-4000
msms.org/ASMSheraton

Exhibitor and Sponsors Online Materials

Thank You, Exhibitors and Sponsors!

The MSMS Foundation would like to offer our sincere gratitude for the support of the 2018 sponsors and exhibitors.

• AstraZeneca 
• Advantage Technologies
• AGI - Medical
• FistuRasper - 4 individual raspers to remove plate epithelium from fistulas for fistulotomy
  mProtect 3 - Guard for circular staplers to protect mucosa and dilate prior to anastomosis
• Association Gloves & Supplies
  Association Gloves & Supplies is endorsed by the MSMS to help members reduce the cost of various medical supplies. A portion of each purchase is returned to the MSMS as non-dues revenue!
• Blue Cross Blue Shield of Michigan
  Blue Cross Blue Shield of Michigan, is an independent licensee of the Blue Cross and Blue Shield Association. The largest health insurer in Michigan, BCBSM provides and administers health benefits to more than 4.5 million members residing in Michigan, and to employees of Michigan-headquartered companies who reside out of state.
• Covenant Healthcare
• Early on Michigan/Build Up
  Early On is Michigan's system for helping infants and toddlers, birth to age three and their families who have developmental delays or are at risk for delays due to certain health conditions.  It's designed to help families find the social, health and educational services that will promote the development of their infants and toddlers with special needs.
• Indiana University Kelly School of Business, Business of Medicine
  Physician MBA
  

  IU Kelley Physician MBA’s curriculum, focused at the intersection of business and medicine, combines business and leadership fundamentals with strategic healthcare courses designed for physicians. Our 21-month MBA blends online learning with monthly weekend sessions.

• Ingenious Med
• Insmed Incorporated
• Insmed is a biopharmaceutical company focused on the unmet needs of people with rare conditions, like nontuberculous mycobacterial (NTM) lung disease.
• Intermark Stone Mountain Surgical
  RetroWash Kit - Do a bowel clean out and colonoscopy on the table. 
  ProctoWash Kit - Lavage kit to remove cancerous cells in the rectal stump.
• MAQI2 (Michigan Anticoagulation Quality Improvement Initiative)
  Michigan Anticoagulation Quality Improvement Initiative (MAQI2), a consortium of anticoagulation clinics and experts from across the state of Michigan, produced an anticoagulation toolkit to provide practitioners with an up-to-date, reliable, and easy to use source of information for anticoagulation. The content is based on the latest available evidence-based guidelines and research whenever possible, and is available online at www.anticoagulationtoolkit.org. It I currently available in Spanish, Arabic and Chinese.  The toolkit is also available as an app for both for iPhones.
• MDCH - Physician Peer Education Project on Immunization
• Medtronic
  Through innovation and collaboration, Medtronic improves the lives and health of millions of people each year. Learn more about our technology, services and solutions at Medtronic.com.
• Meridian Health Plan 
• Michigan State Medical Society
• MSMS Physician Insurance Agency
• Novartis Pharmaceuticals
• Officite
  Officite works with helping physicians grow their practices and generate more new patient referrals through effective, efficient online marketing. Their websites are attractive, powerful and easy to launch. Visit Officite.com.
• ProAssurance
  Our healthcare professional liability solutions make insurance simpler. Get coverage that fits and a pledge of fair treatment. ProAssurance Group is A.M. Best A+ (Superior).
• Professional Review Organization
  Physicians Review Organization is a URAC accredited independent medical review organization.  We provide objective
  ase reviews when there is a question about the appropriateness of medical care or when providers are working to improve the quality of care.Physicians Review Organization is a URAC accredited independent medical review organization.  We provide objective case reviews when there is a question about the appropriateness of medical care or when providers are working to improve the quality of care.
• Reliant Billing Services
  Reliant Billing Services provides first-class certified coding, A/R Recovery, credentialing and IT consulting services. Our team can take care of all your non-clinical needs and relieve you of administrative burdens. We work closely with our clients to ensure that every step of the revenue cycle is optimized.
• THD America
  Anopress - Anorectal manometry for the office, 10 minute test including Balloon Sensation.
  ProctoStation - High Resolution Anoscopy for HIV and HPV patients office setting for biopsy and cautery.  
  SlideOne -  Ligation of internal hemorrhoids using Doppler
  LED Scopes - Ano and Rectosigmoid scopes with internal light and insufflation
• The Doctors Company
  The Doctors Company is the nation’s largest physician-owned medical malpractice insurer, with 79,000 members and over $4.8 billion in assets. Discover how we are taking the mal out of malpractice insurance at thedoctors.com.
• US Army Medical Recruiting
  When you join the Army healthcare team you become a member of a comprehensive healthcare systems. You practice high-tech healthcare in a variety of settings; clinics, hospitals, field medical units, and many army medical facilities at military post around the world.

Are you interested in exhibiting and/or sponsoring the 2018 Annual Scientific Meeting?

Space is limited so please act now! For more information, contact Beth Elliott at 517-336-5789